Home

JOHN STUART PATTON

CIK 1247653 · Chief Scientific Officer · last filed 2014-08-21

JOHN STUART PATTON is a Chief Scientific Officer who has filed 38 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for HTI, was dated Aug 21, 2014. Across all open-market trades the lifetime net is −$5.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.45M

Companies

2

Total Filings

38

Lifetime Open-Market Net

-$4.96M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HALOZYME THERAPEUTICS, INC. (HTI) Delisted Director 179,876 — — -$4.96M 30 2014-08-21
NKTR Chief Scientific Officer 20,976 $69.36 $1.45M -$3.3K 8 2008-11-18

Recent Filings

38 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-08-21 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Mixed — -$593.2K EDGAR
2013-09-16 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Mixed +25,000 -$646.0K EDGAR
2013-05-16 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) +20,000 $0 EDGAR
2012-05-04 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) +20,000 $0 EDGAR
2011-05-06 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) +20,000 $20 EDGAR
2010-05-06 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) +20,000 $20 EDGAR
2009-05-08 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) +20,000 $20 EDGAR
2008-11-18 NKTR Mixed −3,260 -$3.3K EDGAR
2008-05-09 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) +15,000 $74.1K EDGAR
2008-02-27 NKTR Grant (A) — $0 EDGAR
Showing 1–10 of 38
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.